Eisai
4523.T
#1545
Rank
A$17.14 B
Marketcap
$60.60
Share price
2.29%
Change (1 day)
-35.37%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : A$4.90 B

According to Eisai's latest financial reports the company's total liabilities are A$4.90 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31A$4.94 B-3.41%
2022-03-31A$5.11 B18.7%
2021-03-31A$4.30 B-20.98%
2020-03-31A$5.45 B2.24%
2019-03-31A$5.33 B0.16%
2018-03-31A$5.32 B6.3%
2017-03-31A$5.00 B8.63%
2016-03-31A$4.61 B-6.32%
2015-03-31A$4.92 B5.39%
2014-03-31A$4.67 B-11.1%
2013-03-31A$5.25 B-22.24%
2012-03-31A$6.75 B-8.71%
2011-03-31A$7.40 B-6.5%
2010-03-31A$7.91 B-25.44%
2009-03-31A$10.61 B45.69%
2008-03-31A$7.28 B202.2%
2007-03-31A$2.41 B-12.1%
2006-03-31A$2.74 B11.83%
2005-03-31A$2.45 B-1.88%
2004-03-31A$2.50 B-12.52%
2003-03-31A$2.85 B9.09%
2002-03-31A$2.62 B-21.22%
2001-03-31A$3.32 B